Close menu

November 2nd, 2020 | 09:07 CET

Ballard Power, Saturn Oil & Gas, Amazon - The profiteers of the crisis!

  • Covid-19
Photo credits:

The profiteers of the first wave of the Corona pandemic are seen from the most recently published quarterly figures. The well-known FAANG stocks Facebook, Amazon, Apple, Netflix and Alphabet (Google) were able to improve their balance sheets significantly. Besides some winners, the number of losers is much larger. These now either have to fight for survival or are swallowed cheaply by financially more robust competitors. The takeover wave should pick up speed in 2021, across all industries!

time to read: 2 minutes | Author: Stefan Feulner
ISIN: CA80412L1076 , CA0585861085 , US0231351067

Table of contents:

    The pike in the carp pond

    Due to the sharp drop in prices, there are also great opportunities in the oil market to grow disproportionately through acquisitions. The prerequisite is that you are blessed with cash and have already localized the possible takeover targets. For John Jeffrey, the experienced CEO and Chairman of Saturn Oil & Gas, the current circumstances are just perfect. For Jeffrey, it is clear that buying in competitors offers clear advantages over its own drilling program. The current market capitalization of the Canadians is currently at favorable EUR 15 million. Targeted acquisitions would take the Company into new dimensions.

    Strategically sensible

    Understandably, Jeffrey is keen not to produce at a much higher cost in the future than at present. In 2019, Saturn Oil & Gas was by far the cheapest oil producer in Canada. At only around USD 12 per barrel of oil, the production costs were significantly lower than those of the large, well-known oil producers, which had production costs of well over USD 30 per barrel.

    Change in management indicates growth

    Only yesterday, the news came in that Saturn Oil & Gas will continue to strengthen its position. Wendy Woolsey is joining the team headed by Jeffrey on an interim basis. Woolsey herself has more than 25 years of experience in the Canadian oil and gas industry. She served as Vice President, Finance and Chief Financial Officer of Yoho Resources Inc. from 2005 to 2016 and before that as Manager of Finance at Baytex Energy and Vice President, Finance and Chief Financial Officer of Symmetry Resources Inc. For Jeffrey, this is another coup and possibly a sign of further growth for Saturn Oil & Gas Inc. We can be excited about what will follow in the coming weeks.

    Strong partnership

    Good news at Ballard Power. The Canadians have reached a final agreement with the automotive giant Audi on the extended use of the FCgen HPS fuel cell stack. According to the press release, the marketing of the new fuel cell development can start worldwide and across all industries, including trucks and passenger cars. Previously, Ballard had only the right to use the stack for a limited number of applications, including bus, rail, marine, mining, construction, aviation and stationary power applications.

    Caution advised

    Despite the very positive news, caution is advised at one of the leading fuel manufacturers. After the ongoing strong correction, the resistance zone, which was successfully defended last week, has to hold at around CAD 16.50. If not, the next way would be the 200-day line, which currently runs at approx. CAD 13.50.


    One could guess that the figures for the third quarter would be positive. However, these even beat all analysts' estimates by a wide margin. Amazon increased its sales in the reporting period by 37% to USD 96.1 billion. Operating income rose to USD 6.2 billion, compared to USD 3.2 billion in the same period of the previous year. Earnings per share exploded to USD 12.37. Analysts had "only" expected proceeds of USD 93 billion, but they were clearly off target for earnings per share. They estimated this at only USD 7.41. With the recent lockdowns in almost all of Europe, nothing should stand in the way of an absolute record year.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.

    Der Autor

    Stefan Feulner

    The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
    He is passionate about analyzing a wide variety of business models and investigating new trends.

    About the author

    Related comments:

    Commented by Mario Hose on January 14th, 2022 | 12:17 CET

    Natural active ingredient against Covid-19: BioNTech, Cardiol, Novavax, Valneva in focus

    • Covid-19

    At the end of the week, trading on the German stock exchanges has been rather slow so far. The German leading index DAX is quoted at a level of 15,922 points and thus around 0.01% up. The index of the second tier, MDAX, traded last at 34,626 points (-0.11%), TecDAX at 3,537 points (-0.67%) and SDAX at 15,904 points with 0.43% in the red. A study from the U.S. will influence the future development of vaccine manufacturers in connection with Covid-19, according to initial research.


    Commented by Mario Hose on January 13th, 2022 | 18:11 CET

    New research results for Covid-19: BioNTech, Cardiol, Valneva

    • Covid-19

    In the afternoon of today's trading day, the German indices extended the price losses in part after a brief recovery phase. The DAX is currently trading at 15,963 points, down around 0.41%. The psychological mark of 16,000 points was exceeded at midday in phases by more than 75 points. The MDAX last traded at 34,708 points (-0.62%), TecDAX at 3,577 points (-2.26%) and SDAX at 15,976 points with 0.66% in the red. New research results for the treatment and prevention of Covid-19 provide an exciting perspective for investors.


    Commented by Mario Hose on January 12th, 2022 | 10:53 CET

    Trading stocks after EMA warning in focus: BioNTech, Johnson + Johnson, Moderna

    • Covid-19

    On Wednesday, the German indices began with a positive sign. The German benchmark index DAX is currently quoted at a level of 16,004 points and thus around 0.04% slightly up. The companies in the second tier can also hold their ground and the MDAX last traded at 34,864 points (+0.26%), TexDAX at 3,644 points and thus 0.60% lower than the previous day. SDAX also loses and last traded at 15,969 points (-0.23%).